Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Equillium Inc
(NQ:
EQ
)
1.150
+0.060 (+5.52%)
Streaming Delayed Price
Updated: 3:36 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Equillium Inc
< Previous
1
2
3
4
5
Next >
Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
November 10, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium to Present at Two Upcoming Investor Conferences
November 09, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium Presents Clinical Data from EQUALISE Phase 1b Study in Lupus Patients at the American Society of Nephrology Annual Meeting
November 05, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium Presents Interim Safety Data from First Cohort of Asthma Patients in Phase 1b EQUIP Study at the American College of Allergy, Asthma & Immunology Meeting
November 05, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Two Abstracts Accepted for Presentation at the 63rd ASH Annual Meeting and Exposition
November 04, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium Reveals Early Safety Data For Itolizumab In Lupus Patients
November 02, 2021
Equillium Inc (NASDAQ: EQ) announced interim data from the Type A portion of the Phase 1b EQUALISE study in systemic lupus erythematosus (SLE) patients. Data were...
Via
Benzinga
Equillium Announces Interim Safety Data and Reduction in Proteinuria for Lupus Patients Treated with Itolizumab in the EQUALISE Study Presented at the ACR Annual Meeting
November 02, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Two Abstracts Accepted for Presentation at the Upcoming Virtual 2021 American Society of Nephrology Annual Meeting
October 18, 2021
From
Equillium, Inc.
Via
Business Wire
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021
September 30, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
September 22, 2021
From
Equillium, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021
September 15, 2021
Upgrades For Alcoa Corp (NYSE:
Via
Benzinga
Equillium to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
From
Equillium, Inc.
Via
Business Wire
60 Biggest Movers From Yesterday
August 24, 2021
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Via
Benzinga
Equillium's Itolizumab Reduces Urine Protein In Lupus Patients
August 12, 2021
Equillium Inc (NASDAQ: EQ) announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 11, 2021
Gainers Hims & Hers Health (NYSE:HIMS)...
Via
Benzinga
Equillium Announces Update to EQUALISE Study of Itolizumab in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
August 11, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
August 10, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium to Present at the BTIG Virtual Biotechnology Conference
August 05, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab
July 13, 2021
Equillium Inc (NASDAQ: EQ) completed an End-of-Phase 1 meeting with the FDA, confirming to advance itolizumab into a single Phase 3 pivotal study in first-line...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
July 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's After-Market Session
July 12, 2021
Gainers SCWorx (NASDAQ:WORX) shares rose...
Via
Benzinga
64 Biggest Movers From Friday
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Friday's Intraday Session
June 11, 2021
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...
Via
Benzinga
Equillium's Itolizumab Shows Rapid, Durable Responses In Graft-Versus-Host-Disease Patients
June 11, 2021
Equillium Inc (NASDAQ: EQ) has announced positive topline data from the Phase 1b EQUATE study evaluating itolizumab in first-line acute graft-versus-host-disease (...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 09, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...
Via
Benzinga
46 Biggest Movers From Yesterday
April 21, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it...
Via
Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.